Shuttle Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -633 | -289 | -1 | |
EBITDA | -1,507 | -2,307 | -2,327 | -3,684 |
EBIT | -2,140 | -2,596 | -2,328 | -3,684 |
Net Income | -2,152 | -2,614 | -2,347 | -3,706 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,417 | -973 | -2,626 | -3,355 |
Cash | 1,089 | 334 | 2,094 | 4,817 |
Basic Shares | 503 | 202 | 223 | 112 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -290 | -5 | -6 | -5 |
EBITDA | -11,360 | -7,779 | -3,990 | -4,319 |
EBIT | -11,650 | -7,784 | -3,997 | -4,325 |
Net Income | -11,721 | -9,144 | -6,592 | -4,996 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,481 | -7,327 | -5,600 | -2,710 |
Cash | 334 | 1,920 | 2,576 | 8,417 |
Basic Shares | 163 | 1,032 | 1,590 | 1,035 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$4.27 |
2025-12-31 | -$12.92 |
2025-09-30 | -$1.05 |
2025-06-30 | -$3.29 |